ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,150	3,053	5,140	2,578	3,752	8,499
Market Cap Growth	34.46%	-40.60%	99.40%	-31.29%	-55.85%	28.98%
Enterprise Value	3,445	2,537	4,852	2,204	3,278	7,904
Last Close Price	24.60	18.35	31.31	15.92	23.34	53.46
PE Ratio	18.56	13.48	-	-	-	-
Forward PE	43.00	35.90	27.40	-	-	-
PS Ratio	4.03	3.19	7.08	4.98	7.75	19.24
PB Ratio	5.04	4.17	11.91	6.44	6.94	13.56
P/TBV Ratio	5.86	4.98	14.04	6.44	6.94	13.58
P/FCF Ratio	22.18	19.42	308.70	-	-	-
P/OCF Ratio	22.09	19.36	307.78	-	-	-
EV/Sales Ratio	3.38	2.65	6.68	4.26	6.77	17.89
EV/EBITDA Ratio	33.13	25.33	-	-	-	-
EV/EBIT Ratio	38.15	30.11	-	-	-	-
EV/FCF Ratio	18.41	16.14	291.36	-	-	-
Debt / Equity Ratio	0.07	0.07	0.13	0.16	0.12	0.08
Debt / EBITDA Ratio	0.49	0.47	-	-	-	-
Debt / FCF Ratio	0.30	0.33	3.44	-	-	-
Asset Turnover	0.95	0.99	1.09	0.80	0.65	0.56
Inventory Turnover	8.30	13.33	18.53	51.22	29.44	35.81
Quick Ratio	2.67	2.18	2.13	3.82	6.10	6.44
Current Ratio	2.91	2.38	2.42	4.04	6.43	6.77
Return on Equity (ROE)	33.18%	38.89%	-14.73%	-45.89%	-28.75%	-42.47%
Return on Assets (ROA)	5.27%	5.44%	-6.86%	-21.70%	-14.37%	-18.66%
Return on Capital (ROIC)	7.77%	8.27%	-9.64%	-26.18%	-16.62%	-21.09%
Return on Capital Employed (ROCE)	10.10%	10.60%	-	-	-	-
Earnings Yield	5.35%	7.42%	-1.19%	-8.38%	-4.47%	-3.31%
FCF Yield	4.51%	5.15%	0.32%	-4.42%	-3.38%	-1.69%
Buyback Yield / Dilution	-1.10%	-1.55%	-1.32%	-0.74%	-2.01%	-6.88%

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q